State and private sector innovation and the future of US health care

Speakers

Keynote Speaker:  United States Senator Bill Cassidy (R-LA)

Mark B. McClellan, MD, PhD, Director and Robert J. Margolis, MD, Professor of Business, Medicine and Health Policy

Shubham Singhal, Senior Partner, Global Leader, Healthcare Practice, McKinsey & Co.

Jason Helgerson, Medicaid Director, New York State Department of Health

Thomas Barker, Partner and Co-Chair of the Healthcare Practice, Foley Hoag

Tim Ward, Senior Partner, McKInsey & Co.

Aaron McKethan, PhD, Senior Policy Fellow, Duke-Margolis Center for Health Policy

Peter Lee, Executive Director, Covered California

Dennis Matheis, President Central Region & Exchange, Anthem

Erica Hutchins Coe, Partner and Co-Lead, McKinsey's Center for US Health System Reform, McKinsey & Co.

David T. Feinberg, MD, MBA, President and CEO, Geisinger Health System

J. Mario Molina, MD, President and CEO, Molina Healthcare

David Knott, Senior Partner, McKinsey & Co

McKinsey’s Center for US Health System Reform and the Duke-Margolis Center for Health Policy cordially invite you to a webcast event in Washington, DC to explore the future state of our nation’s healthcare and discuss ways to achieve effective solutions at the national and state levels.

At this pivotal time, this event will bring together policy experts, healthcare thought leaders, senior private sector executives and government leadership to discuss how healthcare leaders are shaping the future of the healthcare system and industry, and navigating through change.

Sessions include:
Navigating the future state of US healthcare
Implementing change at the state level:  Medicaid
Implementing change at the state level:  Individual Markets
Private sector innovators effecting healthcare change
Keynote:  Achieving solutions at the state level

We believe that this event falls within the “Widely Attended Gathering” exception set forth at 5 CFR Part 2635.204(g)(2) which, subject to a determination of agency interest serves as an exception to the general government ethics restrictions. Each portion of the agenda is an integral part of the event during which we would welcome your viewpoint and participation in the exchange of ideas. We recommend that you coordinate with your ethics official for official confirmation of your agency determination and we are happy to provide additional cost information and/or breakdown if helpful.